✦ LIBER ✦

A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma

✍ Scribed by Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. Nelson Jr.; Rafat Abonour; Angie Secrest; Elizabeth Cox; Jay Baute; Cheryl Sullivan; Kathleen Kane; Michael J. Robertson; Sherif S. Farag

Book ID: 116281933
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 324 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.10.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide, etoposide and carbopla

Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas

✍ Mabed, M; Al-Kgodary, T 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma

✍ El Weshi, A; Rahal, M; Abdelsalam, M; Al Husseini, H; Maghfoor, I; Akhtar, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 200 KB

Ifosfamide, etoposide, cytarabine, and d

Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas

✍ P. Schütt; J. Passon; P. Ebeling; A. Welt; S. Müller; K. Metz; T. Moritz; S. See 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Treatment of relapsed or refractory Hodg

Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Ifosfamide, Idarubicin, and Etoposide in

Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation

✍ Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 210 KB

A multicenter phase II trial of etoposid

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

✍ Sun Jin Sym; Dae Ho Lee; Hye Jin Kang; Seung Hyun Nam; Ho Young Kim; Seok Jin Ki 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 292 KB